Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VDR | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | QPCT | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | POLR2A | FIMM | pan-cancer | AAC | -0.48 | 0.01 |
mRNA | CTXN2 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | TBC1D31 | FIMM | pan-cancer | AAC | -0.46 | 0.01 |
mRNA | PTTG1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | HSCB | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | DCAF15 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | STPG1 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | BATF | CCLE | pan-cancer | AAC | 0.14 | 0.01 |